BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28730439)

  • 1. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
    Kruspe S; Giangrande PH
    Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells.
    Thiel WH; Thiel KW; Flenker KS; Bair T; Dupuy AJ; McNamara JO; Miller FJ; Giangrande PH
    Methods Mol Biol; 2015; 1218():187-99. PubMed ID: 25319652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
    Catuogno S; Esposito CL; Giangrande PH
    Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.
    Zhou J; Swiderski P; Li H; Zhang J; Neff CP; Akkina R; Rossi JJ
    Nucleic Acids Res; 2009 May; 37(9):3094-109. PubMed ID: 19304999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
    Bagalkot V; Gao X
    ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Cell-Type-Specific RNA Aptamers Via Live Cell-Based SELEX.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2016; 1421():191-214. PubMed ID: 26965267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.
    Yan AC; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):194-199. PubMed ID: 29883295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
    Wilner SE; Levy M
    Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics.
    Scott TP; Nel LH
    Viruses; 2021 May; 13(5):. PubMed ID: 34064911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.
    Thiel KW; Hernandez LI; Dassie JP; Thiel WH; Liu X; Stockdale KR; Rothman AM; Hernandez FJ; McNamara JO; Giangrande PH
    Nucleic Acids Res; 2012 Jul; 40(13):6319-37. PubMed ID: 22467215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photomodulating Gene Expression by Using Caged siRNAs with Single-Aptamer Modification.
    Zhang L; Chen C; Fan X; Tang X
    Chembiochem; 2018 Jun; 19(12):1259-1263. PubMed ID: 29488297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-siRNA chimeras: Promising tools for targeting HER2 signaling in cancer.
    Dhanya CR; Mary AS; Madhavan M
    Chem Biol Drug Des; 2023 May; 101(5):1162-1180. PubMed ID: 36099164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
    Yoo H; Jung H; Kim SA; Mok H
    Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
    McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
    Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-siRNA chimeras for HIV.
    Takahashi M; Burnett JC; Rossi JJ
    Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.